Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01358877 |
|---|---|
| Brief Title: | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer (APHINITY) |
| First Submitted : | May 20, 2011 |
| First Submitted that Met QC Criteria : | May 20, 2011 |
| First Posted : | May 24, 2011 (Estimate) |
| Results First Submitted : | December 4, 2017 |
| Results First Submitted that Met QC Criteria : | December 4, 2017 |
| Results First Posted : | January 5, 2018 |
| Last Update Submitted that Met QC Criteria : | March 18, 2024 |
| Last Update Posted : | April 10, 2024 |